For the year ending 2025-12-31, HBIO has $80,071K in assets. $66,337K in debts. $8,614K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 8,614 | |||
| Accounts receivable, net | 16,043 | |||
| Inventories | 20,805 | |||
| Other current assets | 2,763 | |||
| Total current assets | 48,225 | |||
| Property, plant and equipment, net | 4,787 | |||
| Operating lease right-of-use assets | 7,172 | |||
| Goodwill | 9,559 | |||
| Intangible assets, net | 7,639 | |||
| Other long-term assets | 2,689 | |||
| Total assets | 80,071 | |||
| Current portion of long-term debt | 0 | |||
| Accounts payable | 3,652 | |||
| Contract liabilities | 3,447 | |||
| Other current liabilities | 14,861 | |||
| Total current liabilities | 21,960 | |||
| Long-term debt, net | 35,870 | |||
| Deferred tax liability | 317 | |||
| Operating lease liabilities | 6,882 | |||
| Other long-term liabilities | 1,308 | |||
| Total liabilities | 66,337 | |||
| Common stock, par value 0.01 per share, 80,000,000 shares authorized 44,719,894 shares issued and outstanding at december 31, 2025 44,074,475 shares issued and outstanding at december 31, 2024 | 447 | |||
| Additional paid-in-capital | 239,669 | |||
| Accumulated deficit | -214,710 | |||
| Accumulated other comprehensive loss | -11,672 | |||
| Total stockholders' equity | 13,734 | |||
| Total liabilities and stockholders' equity | 80,071 | |||
HARVARD BIOSCIENCE INC (HBIO)
HARVARD BIOSCIENCE INC (HBIO)